MBX Biosciences Inc (NAS:MBX)
$ 62.08 -1.57 (-2.47%) Market Cap: 2.95 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 6.75 GF Score: 12/100

MBX Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 11:45 PM GMT
Release Date Price: $36.31 (-0.44%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MBX.OQ - MBX Biosciences Inc
MBX Biosciences Inc at JPMorgan Healthcare Conference
Jan 13, 2026 / 11:45PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great, good afternoon, everyone. Welcome. My name's Jessica. I'm a biotech analyst at JPMorgan, and we're continuing our 44th annual healthcare conference today with MBX. First you're going to hear a, presentation from the company, and then we're going to go into some Q&A. So if you're in the room here and you have a question, just raise your hands, someone will. Come over with a microphone or, alternatively, you can also submit questions online and I can read them off the iPad up here. But with that, let me turn it over to MBX's CEO Ken Harlech.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot